GAP vs WST · P/E 9.9, rev $15.09B vs P/E 35, rev $2.89B
The Gap, Inc. (GAP) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
GAP currently screens at market cap $7.73B and trailing P/E 9.9. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the GAP and WST stock pages for the full models.
Not investment advice.